Vascular Manifestations of Systemic Autoimmune presents in one volume the clinical syndromes associated with small and large vessel pathology encountered in the autoimmune connective tissue disorders and includes the pathogenesis, clinical implications, and treatment of these diseases. Now that most individuals survive the onset of acute systemic autoimmune diseases and live for decades more, halting the long-term attack on vasculature is increasingly important. It addresses the most current therapies available for treatment (fibrolytic treatments, prostacycline derivatives, and anti-platelet compounds) and includes a separate chapter devoted to the use of long term anticoagulation and the newer low molecular weight heparins.